Skip to main content

PROCEPT BioRobotics Corp

PRCT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001588978

In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding PROCEPT BioRobotics Corp changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of PRCT: Q2 2023 compared with Q3 2023
MeasureQ2 2023Of which not filed for Q3 2023Q3 2023Change
Holders1201127+8
Shares36.0M10044.5M+8.46M (+23.5%)
Value$1.27B$4.00K$1.46B+$188.5M (+14.8%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held PROCEPT BioRobotics Corp at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PRCT in Q3 2023
InstitutionSharesValue% of portfolio
Champlain Investment Partners, LLC1,568,394$51.5M0.33%
Wellington Management Group LLP804,752$26.4M0.01%
Point72 Europe (London) LLP406,271$13.3M1.81%
Braidwell LP331,061$10.9M0.34%
ArrowMark Colorado Holdings LLC111,614$3.66M0.04%
Essex Investment Management Co LLC60,034$1.97M0.32%
First Trust Advisors LP49,537$1.63M0.00%
Squarepoint Ops LLC29,382$964.0K0.00%
Balyasny Asset Management LLC26,737$877.2K0.00%
Monashee Investment Management LLC25,693$843.0K0.35%
Wolverine Trading, LLC19,449$638.1K0.01%
Dark Forest Capital Management LP17,781$583.4K0.05%
VELA Investment Management, LLC17,730$581.7K0.26%
Bessemer Group Inc15,715$516.0K0.00%
Pacific Capital Partners Ltd14,346$470.7K0.28%
Diversified Trust Co9,713$318.7K0.01%
M&T Bank Corp8,922$292.7K0.00%
Occudo Quantitative Strategies LP8,217$269.6K0.03%
Ronald Blue Trust, Inc.2,009$71.0K0.00%
Comerica Bank263$8.63K0.00%
The PNC Financial Services Group, Inc.34$1.12K0.00%
Farther Finance Advisors, LLC5$1640.00%

Sold out (14)

Institutions that held PROCEPT BioRobotics Corp at the end of Q2 2023 and filed for Q3 2023 without it.

Not filed for Q3 2023 yet (1)

Institutions that held PROCEPT BioRobotics Corp at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PRCT in Q2 2023 that haven't filed for Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
Vigilant Capital Management, LLC100$4.00K